Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is clozapine a mood stabilizer?

C A Zarate1, M Tohen, M D Banov

  • 1Pharmacoepidemiology Center, McLean Hospital, Belmont, Mass 02178.

The Journal of Clinical Psychiatry
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.

bioRxiv : the preprint server for biology·2025
Same author

A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention.

International journal of bipolar disorders·2023
Same author

The effects of ketamine on typical and atypical depressive symptoms.

Acta psychiatrica Scandinavica·2020
Same author

Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.

Molecular psychiatry·2017
Same author

Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

Molecular psychiatry·2017
Same author

Animal models to improve our understanding and treatment of suicidal behavior.

Translational psychiatry·2017

Clozapine monotherapy effectively stabilizes mood in severe bipolar disorder patients who have not responded to other treatments. This approach reduces affective episodes and hospitalizations, offering a new treatment avenue.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Clozapine shows efficacy in acute and maintenance treatment of bipolar disorders.
  • Investigated clozapine's effectiveness as a standalone mood stabilizer for refractory bipolar disorder.

Purpose of the Study:

  • To evaluate clozapine monotherapy as a mood stabilizer in patients with treatment-resistant bipolar disorders.

Main Methods:

  • Retrospective review of 17 patients with bipolar disorder or schizoaffective disorder, bipolar type, treated with clozapine monotherapy.
  • Patients were older than 16 years and had refractory illness.
  • Assessed response using Clinical Global Impressions-Improvement (CGI-I) scale and follow-up interviews.

Main Results:

  • 65% of patients remained on clozapine monotherapy with no rehospitalization or affective episodes.

Related Experiment Videos

  • Significant decrease in rehospitalization rates compared to pre-clozapine treatment (p = .025).
  • Significant improvement in CGI-I scores observed (p = .02).

    • Conclusions:

    • Clozapine monotherapy is an effective mood stabilizer for severe refractory bipolar illness.
    • It reduces affective episodes and rehospitalizations.
    • Offers a viable treatment option for patients with limited therapeutic alternatives.